USPTO serial 79284229
EVERZOM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 19, 2021
- Examiner
- TULLY, MATTHEW
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with EVERZOM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Arnaud Rainfray
Arnaud Rainfray O'Brien Barristers and Sollicitors600-140 Grande-Allee EstQuebec City, G1R5M8CANADAGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Medical research and pharmacological research services; analysis of human tissues for medical research purposes; pharmaceutical drug development services, namely, development of pharmaceutical preparations and medicines from extracellular vesicles; conducting clinical trials for others; provision of information in connection with medical and scientific research in the field of pharmaceutical products and clinical trials; medical research and laboratory services in the field of human tissue, namely, tissue engineering; medical research services, namely, clinical research in the field of biotherapy; conducting clinical trials for others, namely, carrying out clinical trials for pharmaceutical products; testing on pharmaceutical products; quality control for others, namely, quality evaluation of pharmaceutical products; research and development in the field of pharmaceuticals and biotechnology; medical research services, namely, biological, clinical and medical research services in the field of biotherapy; scientific research for medical purposes in the field of biotherapy; scientific research in the field of extracellular vesicles, namely, scientific research in the field of analysis, isolation and production of extracellular vesicles; laboratory research services concerning pharmaceutical products; stem cell research; scientific research and development in the field of microorganisms and cells; scientific research and development in the field of extracellular vesicles; scientific research services with respect to the isolation and cultivation of human cells and tissues | ACTIVE | — |
| 044 | Medical services, namely, regenerative medicine services using extracellular vesicles; stem cell therapy services, namely, therapy services based on stem cells; biotherapy services, namely, health care therapy services for treating cancer, cardiovascular diseases, acute kidney injury, brain injury, liver injury, osteoarthrisis, bone regeneration, lung injury, cutaneous wound healing, fistula, stenosis, radio induced fibrosis, autoimmune diseases, lysosomal storage disorders, degenerative diseases, using extracellular vesicles; biotherapy services, namely, medical services relating to the collection, treatment and processing of human cells | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 19, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 24, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 16, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 23, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 23, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 19, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 19, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 3, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 3, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 14, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 28, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 28, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 28, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 28, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 28, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 9, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 8, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 8, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 18, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 1, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 30, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 31, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 30, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 5, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 1, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 30, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |